COMMUNIQUÉS West-GlobeNewswire

60 Degrees Pharmaceuticals Announces Closing of up to $10 Million Public Offering
16/07/2025
$5 million received upfront with up to an additional $5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants WASHINGTON, July 16, 2025 (GLOBE NEWSWIRE) -- 60 Degrees [...]
Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025
16/07/2025
BEDFORD, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its second quarter [...]
Outset Medical to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
16/07/2025
SAN JOSE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, [...]
Glass House Brands Announces Preferred Equity Refinancing
16/07/2025
LONG BEACH, Calif. and TORONTO, July 16, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest- [...]
Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal
16/07/2025
Revised Potential Distribution Range of $0.03 to $0.07 per share based on current estimates and assumptions Failure to approve Dissolution Proposal on a timely basis will result in continued operating costs and further [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
16/07/2025
CONSHOHOCKEN, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time
16/07/2025
GERMANTOWN, Md., July 16, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose [...]
BriaCell Therapeutics Announces Closing of $15 million Public Offering
16/07/2025
PHILADELPHIA and VANCOUVER, British Columbia, July 16, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company [...]
Teladoc Health to Announce Second Quarter 2025 Financial Results
16/07/2025
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release second quarter 2025 results on Tuesday, July 29, 2025, after the market [...]
Avicanna Announces Closing of Non-Brokered Private Placement
16/07/2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS TORONTO, July 16 [...]
NKGen Biotech Announces New Funding to Regain Compliance with Reporting Obligations and Listing Standards
16/07/2025
Funding in the amount of $2.0M from Japanese strategic investor, in the form of common equity PIPE with warrants. New funding provides for necessary resources to regain compliance with reporting obligations and listing [...]
Virbac: au premier semestre 2025, le chiffre d'affaires a enregistré une solide croissance de +5,6% à taux de change et périmètre constants
16/07/2025
CHIFFRES CLÉS Chiffre d’affaires du 1 er semestre 2025 738,3 M€ Croissance à taux de change et périmètre constants 1 +5,6% dont animaux de compagnie +7,1% animaux d’élevage +5,1% Croissance à taux de change constants 2 [...]
Virbac: in the first half of 2025, revenue recorded solid growth of +5.6% at constant exchange rates and scope of consolidation
16/07/2025
KEY FIGURES Revenue in first half of 2025 €738.3M Growth at constant exchange rates and scope 1 +5.6 including companion animals +7.1% farm animals +5.1% Growth at constant exchange rates 2 +7.8% Overall change +5.0% [...]
eMI Aesthetics Announces Launch of AI-Powered Aesthetic Simulation Platform for Cosmetic Treatment Visualization
16/07/2025
Miami, FL, July 16, 2025 (GLOBE NEWSWIRE) -- eMI Aesthetics , a leader in AI-driven cosmetic imaging, today announced the launch of its AI-powered aesthetic simulation platform for cosmetic treatment visualization. With [...]
Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha Launch
16/07/2025
Advanced algorithms aim to reduce trial planning timelines, accelerating time-to-market for new therapies Initiative to support Tevogen Bio’s ExacTcell™ pipeline with a goal of enhancing commercial viability and [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 28 - 2025
16/07/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 07 juillet au 11 juillet 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2025
16/07/2025
Aggregated presentation by day and by market Statement of transactions in own shares from July 7th to July 11th 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code identifiant de [...]
Bilan semestriel du contrat de liquidité avec Invest Securities
16/07/2025
Bilan semestriel du contrat de liquidité avec Invest Securities Nantes, le 16 juillet 2025, 18 heures – Au titre du contrat de liquidité confié par OSE Immunotherapeutics à Invest Securities , les moyens suivants [...]
Half-Year Report on Liquidity Contract with Invest Securities
16/07/2025
Half-Year Report on Liquidity Contract with Invest Securities NANTES, France - July 16, 2025, 6:00pm CET – Under the liquidity contract entrusted by OSE Immunotherapeutics to Invest Securities , the following assets [...]

Pages